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The Efficacy of Electrocardiograms as a Screening Tool to Detect
Cardiac Abnormalities in Young Athletes
Abstract
• Sudden cardiac death (SCD) among athletes can be attributed
to increased cardiovascular demands associated with vigorous
exercise.
• The majority of athletes who experience sudden cardiac death
are asymptomatic.
• Pre-participation history and physicals, (H&P) help to
identify underlying cardiovascular disorders with the
potential to increase the risk of SCD in an athlete.
• The efficacy of pre-participation H&Ps to identify underlying
cardiac etiology has been debated.
• The purpose of this research is to:
– Determine incidence and cause of SCD among athletes
(Table 1).

Discussion

Research Questions
• In athletes <35 years of age, will the addition of an ECG to
the H&P exam, compared to an isolated H&P, improve the
detection of occult cardiac conditions, decreasing the
incidence of sudden cardiac death?
• With the addition of the ECG to the pre-participation H&P,
what criteria will reduce the number of false-positives,
improving the specificity of the ECG for detecting cardiac
abnormalities?
• Is the ECG a cost-effective component, compared to the sole
H&P exam that is currently required for athlete participation
in competitive sports?

• Drezner et al. (2011) report the incidence of sudden cardiac
death in the United States in high school athletes aged 14-17
years old is 1/23,000.
• Maron et al. (2007) reported incidence of SCD to be
1/166,000 in competitive athletes aged 12-35 years.
• The low incidence of SCD in the United States drives
screening recommendations and supports debates over cost
and the efficacy of the ECG with the H&P.

Applicability to Clinical
Practice
• Utilization of an ECG does not replace the H&P exam.
• The refined criteria is paramount to interpret ECGs in athletes
and reduce false-positives.
• AHA recommends against routine use of an ECG for
screening in athletes. (Drezner et al., 2011).
• Rodday et al. (2012) a screening program needs “high preclinical prevalence in the screened population, a highly
discriminatory test, the disease is serious, and asymptomatic
treatment decreases morbidity and mortality.”
• Drezner et al. (2011) Prevalence of cardiovascular conditions
with the potential for SCD should dictate screening
procedures, rather than the incidence of SCD.

Table 1. Causes of Sudden Cardiac Death Among Athletes in the United States

Table 2. Refined ECG Criteria for Screening Athletes

– Determine the efficacy and evidenced-based criteria for the
interpretation of ECGs in athletes.
– Evaluate cost-effectiveness of screening with ECG.
• The findings indicate:
– Incidence of SCD is 1-3/100,000 athletes.

– The addition of ECG to the H&P improves sensitivity to
70% and specificity to 94.1% resulting in early detection of
cardiac abnormalities and decreases the incidence of SCD.
– The refined criteria significantly reduces false-positive rates
for ECG interpretation (p<0.0001).
– The ECG saves an additional 2.1 life years/1000 athletes
screened at a cost of $88.

Introduction
• Sudden Cardiac Death:
– death occurring in a patient with previously stable cardiac
function until time of collapse.
– cardiac demise taking place within one hour of symptom
onset.
• Athletes presumed to be healthy and in good condition are
often affected by SCD due to cardiac abnormalities
undetected by history and physical exam.
• Cardiovascular screening is a diagnostic tool to improve a
clinician’s plan of care and decrease SCD in athletes.

Statement of the Problem
• The pre- participation sports examination traditionally
consists of a H&P.
• The efficacy of the pre-participation H&P to identify
underlying cardiac etiology has been debated as
signs/symptoms of SCD may go undetected in the
asymptomatic athlete.
• The athlete’s heart produces normal physiological ECG
changes that mimic pathologic conditions making
interpretation difficult.

Leng, T.K. (2013)

Literature Review
• Athletes not accustomed to exercise are at greater risk for
SCD due to increased sympathetic tone resulting in
arrhythmias.
• Asif et al. (2013) Hypertrophic cardiomyopathy (HCM) and
coronary artery anomalies are the leading identifiable cardiac
causes of SCD in athletes from the United States (Table 1).
• Rodday et al. (2012) reported a prevalence of HCM detected
by ECG of 45/100,000, 84.7% sensitivity, 84.8% specificity
with a number needed to screen to detect one case of 2,624
and 399 false positives (p <0.001).
• Maron et al. (1996) reported 158 sudden deaths among
athletes with 134 having direct cardiovascular causes. 115 of
the 134 had participated in a standard pre-participation H&P,
and only four (3%) were detected as having cardiac disease.
• Sheikh et al. (2014) the refined criteria (Table 2) reduces the
number of ECGs categorized as abnormal from 21.5% to
6.6%, with a significant reduction in the number of abnormal
ECGs in both black and white athletes, to 11.5% and 5.3%
respectively (p<0.0001).
• Borjeson et al. (2011) reported adding the ECG to the H&P
saves 2.06 life-years per 1000 athletes screened, costing USD
42,000 per life-year saved, compared to screening without an
ECG.
• Lampert et al. (2013) reported cost of the H&P exam ranged
from $224 to $313/athlete/year, and ECGs ranged from $39 to
$47/athlete/year, only 15-18% of the combined price.

Sheikh et al. (2014)

• Wisten et al. (2004) reported increased sensitivity for the
ECG to detect cardiovascular abnormalities over the H&P. In
66 cases of SCD, only 18% had a positive family history,
while 82% revealed previous ECG abnormalities.
• Corrado et al. (2006) reported a 10-fold reduction in SCD in
Italy among competitive athletes with an 89% reduction in
deaths as a result of cardiomyopathy when the ECG was
added to the H&P. A 7% false-positive rate and a 2%
disqualification rate.
• Maron et al. (1987) reported a false-positive rate of 15% for
the ECG.
• Riding et al. (2014) maintains that black athletes still have
higher percentages of abnormal ECGs than their Arabic and
Caucasian counterparts.
• Roberts et al. (2013) argues that the high false-positive values
will result in unnecessary secondary testing that will increase
the cost of ECG screening in large populations of athletes.
• Wheeler et al. (2010) maintained that compared with H&P the
addition of the ECG saves 2.1 life years for every 1,000
athletes screened at a cost of $88 per athlete.
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